This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Maximilian David Palkowitz: Innovator in KRAS Inhibitors
Introduction
Maximilian David Palkowitz is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of cancer treatment through his innovative work on KRAS inhibitors. His research focuses on developing compounds that can effectively target and inhibit the KRAS protein, which is often implicated in various cancers.
Latest Patents
Maximilian holds 1 patent related to KRAS inhibitors. This patent outlines methods of treating cancers using the compounds he has developed. His work is crucial in advancing therapeutic options for patients suffering from KRAS-driven malignancies.
Career Highlights
Maximilian is currently employed at Bristol-Myers Squibb Company, a leading biopharmaceutical firm. His role involves extensive research and development aimed at creating innovative treatments for cancer. His expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.
Collaborations
Maximilian has collaborated with esteemed colleagues, including Brian E. Fink and Amit Kumar Chattopadhyay. These partnerships enhance the research efforts and contribute to the development of effective cancer therapies.
Conclusion
Maximilian David Palkowitz is a dedicated inventor whose work on KRAS inhibitors is paving the way for new cancer treatments. His contributions to the field are significant and reflect his commitment to improving patient outcomes.